Biology of Tenascin C and its Role in Physiology and Pathology


Cite item

Full Text

Abstract

Tenascin-C (TNC) is a multimodular extracellular matrix (ECM) protein hexameric with several molecular forms (180-250 kDa) produced by alternative splicing at the pre-mRNA level and protein modifications. The molecular phylogeny indicates that the amino acid sequence of TNC is a well-conserved protein among vertebrates. TNC has binding partners, including fibronectin, collagen, fibrillin-2, periostin, proteoglycans, and pathogens. Various transcription factors and intracellular regulators tightly regulate TNC expression. TNC plays an essential role in cell proliferation and migration. Unlike embryonic tissues, TNC protein is distributed over a few tissues in adults. However, higher TNC expression is observed in inflammation, wound healing, cancer, and other pathological conditions. It is widely expressed in a variety of human malignancies and is recognized as a pivotal factor in cancer progression and metastasis. Moreover, TNC increases both pro-and anti-inflammatory signaling pathways. It has been identified as an essential factor in tissue injuries such as damaged skeletal muscle, heart disease, and kidney fibrosis. This multimodular hexameric glycoprotein modulates both innate and adaptive immune responses regulating the expression of numerous cytokines. Moreover, TNC is an important regulatory molecule that affects the onset and progression of neuronal disorders through many signaling pathways. We provide a comprehensive overview of the structural and expression properties of TNC and its potential functions in physiological and pathological conditions.

About the authors

Malihehsadat Abedsaeidi

Department of Basic Sciences, Faculty of Veterinary Medicine,, Ferdowsi University of Mashhad

Email: info@benthamscience.net

Farzaneh Hojjati

Division of Industrial and Environmental Biotechnology,, National Institute of Genetic Engineering and Biotechnology

Email: info@benthamscience.net

Amin Tavassoli

Division of Biotechnology, Ferdowsi University of Mashhad

Email: info@benthamscience.net

Amirhossein Sahebkar

Biotechnology Research Center, Pharmaceutical Technology Institute,, Mashhad University of Medical Sciences

Author for correspondence.
Email: info@benthamscience.net

References

  1. Giblin, S.P.; Midwood, K.S. Tenascin-C: Form versus function. Cell Adhes. Migr., 2015, 9(1-2), 48-82. doi: 10.4161/19336918.2014.987587 PMID: 25482829
  2. Lowy, C.M.; Oskarsson, T. Tenascin C in metastasis: A view from the invasive front. Cell Adhes. Migr., 2015, 9(1-2), 112-124. doi: 10.1080/19336918.2015.1008331 PMID: 25738825
  3. Midwood, K.S.; Chiquet, M.; Tucker, R.P.; Orend, G. Tenascin-C at a glance. J. Cell Sci., 2016, 129(23), 4321-4327. PMID: 27875272
  4. Midwood, K.S.; Orend, G. The role of tenascin-C in tissue injury and tumorigenesis. J. Cell Commun. Signal., 2009, 3(3-4), 287-310. doi: 10.1007/s12079-009-0075-1 PMID: 19838819
  5. Chiquet, M.; Fambrough, D.M. Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J. Cell Biol., 1984, 98(6), 1926-1936. doi: 10.1083/jcb.98.6.1926 PMID: 6725406
  6. Chiquet-Ehrismann, R.; Matsuoka, Y.; Hofer, U.; Spring, J.; Bernasconi, C.; Chiquet, M. Tenascin variants: Differential binding to fibronectin and distinct distribution in cell cultures and tissues. Cell Regul., 1991, 2(11), 927-938. doi: 10.1091/mbc.2.11.927 PMID: 1725601
  7. Udalova, I.A.; Ruhmann, M.; Thomson, S.J.; Midwood, K.S. Expression and immune function of tenascin-C. Crit. Rev. Immunol., 2011, 31(2), 115-145. doi: 10.1615/CritRevImmunol.v31.i2.30
  8. Zuliani-Alvarez, L.; Marzeda, A.M.; Deligne, C.; Schwenzer, A.; McCann, F.E.; Marsden, B.D.; Piccinini, A.M.; Midwood, K.S. Mapping tenascin-C interaction with toll-like receptor 4 reveals a new subset of endogenous inflammatory triggers. Nat. Commun., 2017, 8(1), 1595. doi: 10.1038/s41467-017-01718-7 PMID: 29150600
  9. Yokosaki, Y.; Monis, H.; Chen, J.; Sheppard, D. Differential effects of the integrins α9β1, alphavbeta3, and alphavbeta6 on cell proliferative responses to tenascin. Roles of the β subunit extracellular and cytoplasmic domains. J. Biol. Chem., 1996, 271(39), 24144-24150. doi: 10.1074/jbc.271.39.24144 PMID: 8798654
  10. Midwood, K.; Sacre, S.; Piccinini, A.M.; Inglis, J.; Trebaul, A.; Chan, E.; Drexler, S.; Sofat, N.; Kashiwagi, M.; Orend, G.; Brennan, F.; Foxwell, B. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat. Med., 2009, 15(7), 774-780. doi: 10.1038/nm.1987 PMID: 19561617
  11. Nikoloudaki, G. Functions of matricellular proteins in dental tissues and their emerging roles in orofacial tissue development, maintenance, and disease. Int. J. Mol. Sci., 2021, 22(12), 6626. doi: 10.3390/ijms22126626 PMID: 34205668
  12. Okada, T.; Suzuki, H. The role of tenascin-C in tissue injury and repair after stroke. Front. Immunol., 2021, 11, 607587. doi: 10.3389/fimmu.2020.607587 PMID: 33552066
  13. Fujimoto, N.; Onishi, K.; Sato, A.; Terasaki, F.; Tsukada, B.; Nozato, T.; Yamada, T.; Imanaka-Yoshida, K.; Yoshida, T.; Ito, M.; Hiroe, M. Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure. J. Card. Fail., 2009, 15(10), 898-905. doi: 10.1016/j.cardfail.2009.06.443 PMID: 19944367
  14. Bourdon, M.A.; Wikstrand, C.J.; Furthmayr, H.; Matthews, T.J.; Bigner, D.D. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res., 1983, 43(6), 2796-2805. PMID: 6342760
  15. Erickson, H.P.; Inglesias, J.L. A six-armed oligomer isolated from cell surface fibronectin preparations. Nature, 1984, 311(5983), 267-269. doi: 10.1038/311267a0 PMID: 6482952
  16. Kruse, J.; Keilhauer, G.; Faissner, A.; Timpl, R.; Schachner, M. The J1 glycoprotein—a novel nervous system cell adhesion molecule of the L2/HNK-1 family. Nature, 1985, 316(6024), 146-148. doi: 10.1038/316146a0 PMID: 2409452
  17. Grumet, M.; Hoffman, S.; Chuong, C.M.; Edelman, G.M. Polypeptide components and binding functions of neuron-glia cell adhesion molecules. Proc. Natl. Acad. Sci., 1984, 81(24), 7989-7993. doi: 10.1073/pnas.81.24.7989 PMID: 6393132
  18. Erickson, H.P.; Taylor, H.C. Hexabrachion proteins in embryonic chicken tissues and human tumors. J. Cell Biol., 1987, 105(3), 1387-1394. doi: 10.1083/jcb.105.3.1387 PMID: 3654758
  19. Chiquet-Ehrismann, R.; Mackie, E.J.; Pearson, C.A.; Sakakura, T. Tenascin: An extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell, 1986, 47(1), 131-139. doi: 10.1016/0092-8674(86)90374-0 PMID: 2428505
  20. Tucker, R.P.; Chiquet-Ehrismann, R. Evidence for the evolution of tenascin and fibronectin early in the chordate lineage. Int. J. Biochem. Cell Biol., 2009, 41(2), 424-434. doi: 10.1016/j.biocel.2008.08.003 PMID: 18761101
  21. Adams, J.C.; Chiquet-Ehrismann, R.; Tucker, R.P. The evolution of tenascins and fibronectin. Cell Adhes. Migr., 2015, 9(1-2), 22-33. doi: 10.4161/19336918.2014.970030 PMID: 25482621
  22. Orend, G.; Tucker, R.P. Did tenascin-C Co-evolve with the general immune system of vertebrates? Front. Immunol., 2021, 12, 663902. doi: 10.3389/fimmu.2021.663902 PMID: 33912190
  23. Jones, F.S.; Jones, P.L. The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling. Dev. Dyn., 2000, 218(2), 235-259. doi: 10.1002/(SICI)1097-0177(200006)218:23.0.CO;2-G PMID: 10842355
  24. Xia, S.; Lal, B.; Tung, B.; Wang, S.; Goodwin, C.R.; Laterra, J. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation. Neuro-oncol., 2016, 18(4), 507-517. doi: 10.1093/neuonc/nov171 PMID: 26320116
  25. Loustau, T.; Abou-Faycal, C.; Erne, W.; zur Wiesch, P.A.; Ksouri, A.; Imhof, T.; Mörgelin, M.; Li, C.; Mathieu, M.; Salomé, N.; Crémel, G.; Dhaouadi, S.; Bouhaouala-Zahar, B.; Koch, M.; Orend, G. Modulating tenascin-C functions by targeting the MAtrix REgulating MOtif, "MAREMO". Matrix Biol., 2022, 108, 20-38. doi: 10.1016/j.matbio.2022.02.007 PMID: 35227929
  26. Midwood, K.S.; Hussenet, T.; Langlois, B.; Orend, G. Advances in tenascin-C biology. Cell. Mol. Life Sci., 2011, 68(19), 3175-3199. doi: 10.1007/s00018-011-0783-6 PMID: 21818551
  27. Hasegawa, M.; Yoshida, T.; Sudo, A. Tenascin-C in osteoarthritis and rheumatoid arthritis. Front. Immunol., 2020, 11, 577015. doi: 10.3389/fimmu.2020.577015 PMID: 33101302
  28. Hamidi, H.; Ivaska, J. Every step of the way: Integrins in cancer progression and metastasis. Nat. Rev. Cancer, 2018, 18(9), 533-548. doi: 10.1038/s41568-018-0038-z PMID: 30002479
  29. Tucker, R.P.; Chiquet-Ehrismann, R. Tenascin-C: Its functions as an integrin ligand. Int. J. Biochem. Cell Biol., 2015, 65, 165-168. doi: 10.1016/j.biocel.2015.06.003 PMID: 26055518
  30. Yoshida, T.; Akatsuka, T.; Imanaka-Yoshida, K. Tenascin-C and integrins in cancer. Cell Adhes. Migr., 2015, 9(1-2), 96-104. doi: 10.1080/19336918.2015.1008332 PMID: 25793576
  31. Hendaoui, I.; Tucker, R.P.; Zingg, D.; Bichet, S.; Schittny, J.; Chiquet-Ehrismann, R. Tenascin-C is required for normal Wnt/β-catenin signaling in the whisker follicle stem cell niche. Matrix Biol., 2014, 40, 46-53. doi: 10.1016/j.matbio.2014.08.017 PMID: 25196097
  32. Chen, S.; Fu, H.; Wu, S.; Zhu, W.; Liao, J.; Hong, X.; Miao, J.; Luo, C.; Wang, Y.; Hou, F.F.; Zhou, L.; Liu, Y. Tenascin-C protects against acute kidney injury by recruiting Wnt ligands. Kidney Int., 2019, 95(1), 62-74. doi: 10.1016/j.kint.2018.08.029 PMID: 30409456
  33. Gherzi, R.; Carnemolla, B.; Siri, A.; Ponassi, M.; Balza, E.; Zardi, L. Human tenascin gene. Structure of the 5′-region, identification, and characterization of the transcription regulatory sequences. J. Biol. Chem., 1995, 270(7), 3429-3434. doi: 10.1074/jbc.270.7.3429 PMID: 7531707
  34. Chiovaro, F.; Chiquet-Ehrismann, R.; Chiquet, M. Transcriptional regulation of tenascin genes. Cell Adhes. Migr., 2015, 9(1-2), 34-47. doi: 10.1080/19336918.2015.1008333 PMID: 25793574
  35. Moritz, S.; Lehmann, S.; Faissner, A.; von Holst, A. An induction gene trap screen in neural stem cells reveals an instructive function of the niche and identifies the splicing regulator sam68 as a tenascin-C-regulated target gene. Stem Cells, 2008, 26(9), 2321-2331. doi: 10.1634/stemcells.2007-1095 PMID: 18617690
  36. Golledge, J.; Clancy, P.; Maguire, J.; Lincz, L.; Koblar, S. The role of tenascin C in cardiovascular disease. Cardiovasc. Res., 2011, 92(1), 19-28. doi: 10.1093/cvr/cvr183 PMID: 21712412
  37. González-González, L.; Alonso, J. Periostin: A matricellular protein with multiple functions in cancer development and progression. Front. Oncol., 2018, 8, 225. doi: 10.3389/fonc.2018.00225 PMID: 29946533
  38. Finch-Edmondson, M.; Sudol, M. Framework to function: Mechanosensitive regulators of gene transcription. Cell. Mol. Biol. Lett., 2016, 21(1), 28. doi: 10.1186/s11658-016-0028-7 PMID: 28536630
  39. Jinnin, M.; Ihn, H.; Asano, Y.; Yamane, K.; Trojanowska, M.; Tamaki, K. Tenascin-C upregulation by transforming growth factor-β in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene, 2004, 23(9), 1656-1667. doi: 10.1038/sj.onc.1207064 PMID: 15001984
  40. Jinnin, M.; Ihn, H.; Asano, Y.; Yamane, K.; Trojanowska, M.; Tamaki, K. Platelet derived growth factor induced tenascin-C transcription is phosphoinositide 3-kinase/Akt-dependent and mediated by Ets family transcription factors. J. Cell. Physiol., 2006, 206(3), 718-727. doi: 10.1002/jcp.20527 PMID: 16245312
  41. Sivasankaran, B.; Degen, M.; Ghaffari, A.; Hegi, M.E.; Hamou, M.F.; Ionescu, M.C.S.; Zweifel, C.; Tolnay, M.; Wasner, M.; Mergenthaler, S.; Miserez, A.R.; Kiss, R.; Lino, M.M.; Merlo, A.; Chiquet-Ehrismann, R.; Boulay, J.L. Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas. Cancer Res., 2009, 69(2), 458-465. doi: 10.1158/0008-5472.CAN-08-2610 PMID: 19147558
  42. Oppong, E.; Flink, N.; Cato, A.C.B. Molecular mechanisms of glucocorticoid action in mast cells. Mol. Cell. Endocrinol., 2013, 380(1-2), 119-126. doi: 10.1016/j.mce.2013.05.014 PMID: 23707629
  43. Ekblom, M.; Fässler, R.; Tomasini-Johansson, B.; Nilsson, K.; Ekblom, P. Downregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and in fibroblasts. J. Cell Biol., 1993, 123(4), 1037-1045. doi: 10.1083/jcb.123.4.1037 PMID: 7693719
  44. Mackie, E.J.; Scott-Burden, T.; Hahn, A.W.; Kern, F.; Bernhardt, J.; Regenass, S.; Weller, A.; Bühler, F.R. Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. Am. J. Pathol., 1992, 141(2), 377-388. PMID: 1379781
  45. Flück, M.; Tunç-Civelek, V.; Chiquet, M. Rapid and reciprocal regulation of tenascin-C and tenascin-Y expression by loading of skeletal muscle. J. Cell Sci., 2000, 113(20), 3583-3591. doi: 10.1242/jcs.113.20.3583 PMID: 11017874
  46. Sarasa-Renedo, A.; Chiquet, M. Mechanical signals regulating extracellular matrix gene expression in fibroblasts. Scand. J. Med. Sci. Sports, 2005, 15(4), 223-230. doi: 10.1111/j.1600-0838.2005.00461.x PMID: 15998339
  47. Lutz, R.; Sakai, T.; Chiquet, M. Pericellular fibronectin is required for RhoA-dependent responses to cyclic strain in fibroblasts. J. Cell Sci., 2010, 123(9), 1511-1521. doi: 10.1242/jcs.060905 PMID: 20375066
  48. Asparuhova, M.B.; Gelman, L.; Chiquet, M. Role of the actin cytoskeleton in tuning cellular responses to external mechanical stress. Scand. J. Med. Sci. Sports, 2009, 19(4), 490-499. doi: 10.1111/j.1600-0838.2009.00928.x PMID: 19422655
  49. Scherer, C.; Pfisterer, L.; Wagner, A.H.; Hödebeck, M.; Cattaruzza, M.; Hecker, M.; Korff, T. Arterial wall stress controls NFAT5 activity in vascular smooth muscle cells. J. Am. Heart Assoc., 2014, 3(2), e000626. doi: 10.1161/JAHA.113.000626 PMID: 24614757
  50. Chiquet, M. Tenascin: An extracellular matrix protein involved in morphogenesis of epithelial organs. Kidney Int., 1992, 41(3), 629-631. doi: 10.1038/ki.1992.96 PMID: 1374137
  51. Akbareian, S.E.; Nagy, N.; Steiger, C.E.; Mably, J.D.; Miller, S.A.; Hotta, R.; Molnar, D.; Goldstein, A.M. Enteric neural crest-derived cells promote their migration by modifying their microenvironment through tenascin-C production. Dev. Biol., 2013, 382(2), 446-456. doi: 10.1016/j.ydbio.2013.08.006 PMID: 23958436
  52. Sahlberg, C.; Aukhil, I.; Thesleff, I. Tenascin-C in developing mouse teeth: Expression of splice variants and stimulation by TGFβ and FGF. Eur. J. Oral Sci., 2001, 109(2), 114-124. doi: 10.1034/j.1600-0722.2001.00990.x PMID: 11347655
  53. Wiese, S.; Faissner, A. The role of extracellular matrix in spinal cord development. Exp. Neurol., 2015, 274(Pt B), 90-99. doi: 10.1016/j.expneurol.2015.05.018 PMID: 26028310
  54. Crossin, K.L.; Hoffman, S.; Grumet, M.; Thiery, J.P.; Edelman, G.M. Site-restricted expression of cytotactin during development of the chicken embryo. J. Cell Biol., 1986, 102(5), 1917-1930. doi: 10.1083/jcb.102.5.1917 PMID: 2422181
  55. Tongiorgi, E. Tenascin-C expression in the trunk of wild-type, cyclops and floating head zebrafish embryos. Brain Res. Bull., 1999, 48(1), 79-88. doi: 10.1016/S0361-9230(98)00149-X PMID: 10210171
  56. Tan, S.S.; Crossin, K.L.; Hoffman, S.; Edelman, G.M. Asymmetric expression in somites of cytotactin and its proteoglycan ligand is correlated with neural crest cell distribution. Proc. Natl. Acad. Sci., 1987, 84(22), 7977-7981. doi: 10.1073/pnas.84.22.7977 PMID: 2446315
  57. Fan, C.M.; Tessier-Lavigne, M. Patterning of mammalian somites by surface ectoderm and notochord: Evidence for sclerotome induction by a hedgehog homolog. Cell, 1994, 79(7), 1175-1186. doi: 10.1016/0092-8674(94)90009-4 PMID: 8001153
  58. Roelink, H.; Augsburger, A.; Heemskerk, J.; Korzh, V.; Norlin, S. Floor plate and motor neuron induction by vhh-1, a vertebrate homolog of hedgehog expressed by the notochord. Cell., 1994, 76(4), 761-775. doi: 10.1016/0092-8674(94)90514-2 PMID: 8124714
  59. Yasuoka, Y. Morphogenetic mechanisms forming the notochord rod: The turgor pressure-sheath strength model. Dev. Growth Differ., 2020, 62(6), 379-390. doi: 10.1111/dgd.12665 PMID: 32275068
  60. Mackie, E.J.; Thesleff, I.; Chiquet-Ehrismann, R. Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro . J. Cell Biol., 1987, 105(6), 2569-2579. doi: 10.1083/jcb.105.6.2569 PMID: 2447094
  61. Tongiorgi, E.; Bernhardt, R.R.; Zinn, K.; Schachner, M. Tenascin-C mRNA is expressed in cranial neural crest cells, in some placodal derivatives, and in discrete domains of the embryonic zebrafish brain. J. Neurobiol., 1995, 28(3), 391-407. doi: 10.1002/neu.480280311 PMID: 8568519
  62. Hoffman, S.; Crossin, K.L.; Edelman, G.M. Molecular forms, binding functions, and developmental expression patterns of cytotactin and cytotactin-binding proteoglycan, an interactive pair of extracellular matrix molecules. J. Cell Biol., 1988, 106(2), 519-532. doi: 10.1083/jcb.106.2.519 PMID: 2448317
  63. Faissner, A.; Roll, L.; Theocharidis, U. Tenascin-C in the matrisome of neural stem and progenitor cells. Mol. Cell. Neurosci., 2017, 81, 22-31. doi: 10.1016/j.mcn.2016.11.003 PMID: 27836730
  64. Song, I.; Dityatev, A. Crosstalk between glia, extracellular matrix and neurons. Brain Res. Bull., 2018, 136, 101-108. doi: 10.1016/j.brainresbull.2017.03.003 PMID: 28284900
  65. Faissner, A. The tenascin gene family in axon growth and guidance. Cell Tissue Res., 1997, 290(2), 331-341. doi: 10.1007/s004410050938 PMID: 9321695
  66. Guillon, E.; Bretaud, S.; Ruggiero, F. Slow muscle precursors lay down a collagen XV matrix fingerprint to guide motor axon navigation. J. Neurosci., 2016, 36(9), 2663-2676. doi: 10.1523/JNEUROSCI.2847-15.2016 PMID: 26937007
  67. Yuasa, S. Bergmann glial development in the mouse cerebellum as revealed by tenascin expression. Anat. Embryol., 1996, 194(3), 223-234. doi: 10.1007/BF00187133 PMID: 8849669
  68. Reinhard, J.; Joachim, S.C.; Faissner, A. Extracellular matrix remodeling during retinal development. Exp. Eye Res., 2015, 133, 132-140. doi: 10.1016/j.exer.2014.07.001 PMID: 25017186
  69. Besser, M.; Jagatheaswaran, M.; Reinhard, J.; Schaffelke, P.; Faissner, A. Tenascin C regulates proliferation and differentiation processes during embryonic retinogenesis and modulates the de-differentiation capacity of Müller glia by influencing growth factor responsiveness and the extracellular matrix compartment. Dev. Biol., 2012, 369(2), 163-176. doi: 10.1016/j.ydbio.2012.05.020 PMID: 22691363
  70. Kardon, G. Muscle and tendon morphogenesis in the avian hind limb. Development, 1998, 125(20), 4019-4032. doi: 10.1242/dev.125.20.4019 PMID: 9735363
  71. Kannus, P.; Jozsa, L.; Järvinen, T.A.H.; Järvinen, T.L.N.; Kvist, M.; Natri, A.; Järvinen, M. Location and distribution of non-collagenous matrix proteins in musculoskeletal tissues of rat. Histochem. J., 1998, 30(11), 799-810. doi: 10.1023/A:1003448106673 PMID: 9988347
  72. Mikic, B.; Wong, M.; Chiquet, M.; Hunziker, E.B. Mechanical modulation of tenascin-C and collagen-XII expression during avian synovial joint formation. J. Orthop. Res., 2000, 18(3), 406-415. doi: 10.1002/jor.1100180312 PMID: 10937627
  73. Imanaka-Yoshida, K.; Matsumoto, K.; Hara, M.; Sakakura, T.; Yoshida, T. The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. Differentiation, 2003, 71(4-5), 291-298. doi: 10.1046/j.1432-0436.2003.7104506.x PMID: 12823230
  74. Imanaka-Yoshida, K.; Yoshida, T.; Miyagawa-Tomita, S. Tenascin-C in development and disease of blood vessels. Anat. Rec., 2014, 297(9), 1747-1757. doi: 10.1002/ar.22985 PMID: 25125186
  75. Ando, K.; Takahashi, M.; Yamagishi, T.; Miyagawa-Tomita, S.; Imanaka-Yoshida, K.; Yoshida, T.; Nakajima, Y. Tenascin C may regulate the recruitment of smooth muscle cells during coronary artery development. Differentiation, 2011, 81(5), 299-306. doi: 10.1016/j.diff.2011.03.002 PMID: 21497984
  76. Imanaka-Yoshida, K. Extracellular matrix remodeling in vascular development and disease; Etiology and Morphogenesis of Congenital Heart Disease, 2016, pp. 221-226. doi: 10.1007/978-4-431-54628-3_29
  77. Ishigaki, T.; Imanaka-Yoshida, K.; Shimojo, N.; Matsushima, S.; Taki, W.; Yoshida, T. Tenascin-C enhances crosstalk signaling of integrin αvβ3/PDGFR-β complex by SRC recruitment promoting PDGF-induced proliferation and migration in smooth muscle cells. J. Cell. Physiol., 2011, 226(10), 2617-2624. doi: 10.1002/jcp.22614 PMID: 21792920
  78. Cohen, E.D.; Ihida-Stansbury, K.; Lu, M.M.; Panettieri, R.A.; Jones, P.L.; Morrisey, E.E. Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway. J. Clin. Invest., 2009, 119(9), 2538-2549. doi: 10.1172/JCI38079 PMID: 19690384
  79. Mund, S.I.; Schittny, J.C. Tenascin-C deficiency impairs alveolarization and microvascular maturation during postnatal lung development. J. Appl. Physiol., 2020, 128(5), 1287-1298. doi: 10.1152/japplphysiol.00258.2019 PMID: 32078464
  80. Gremlich, S.; Roth-Kleiner, M.; Equey, L.; Fytianos, K.; Schittny, J.C.; Cremona, T.P. Tenascin-C inactivation impacts lung structure and function beyond lung development. Sci. Rep., 2020, 10(1), 5118. doi: 10.1038/s41598-020-61919-x PMID: 32198404
  81. Roth-Kleiner, M.; Hirsch, E.; Schittny, J.C. Fetal lungs of tenascin-C-deficient mice grow well, but branch poorly in organ culture. Am. J. Respir. Cell Mol. Biol., 2004, 30(3), 360-366. doi: 10.1165/rcmb.2002-0266OC PMID: 12904321
  82. Yoshida, T.; Yoshimura, E.; Numata, H.; Sakakura, Y.; Sakakura, T. Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells. Virchows Arch., 1999, 435(5), 496-500. doi: 10.1007/s004280050433 PMID: 10592053
  83. Tsunoda, T.; Inada, H.; Kalembeyi, I.; Imanaka-Yoshida, K.; Sakakibara, M.; Okada, R.; Katsuta, K.; Sakakura, T.; Majima, Y.; Yoshida, T. Involvement of large tenascin-C splice variants in breast cancer progression. Am. J. Pathol., 2003, 162(6), 1857-1867. doi: 10.1016/S0002-9440(10)64320-9 PMID: 12759243
  84. Sun, Z.; Schwenzer, A.; Rupp, T.; Murdamoothoo, D.; Vegliante, R.; Lefebvre, O.; Klein, A.; Hussenet, T.; Orend, G. Tenascin-C promotes tumor cell migration and metastasis through integrin α9β1–mediated YAP inhibition. Cancer Res., 2018, 78(4), 950-961. doi: 10.1158/0008-5472.CAN-17-1597 PMID: 29259017
  85. Kohannezhad, K.; Norouzi, S.; Tafazoli, M.; Soleymani, S.; Shahri, N.M.; Tavassoli, A. The in vitro analysis of migration and polarity of blastema cells in the extracellular matrix derived from bovine mesenteric in the presence of fibronectin. Anat. Cell Biol., 2022, 55(2), 229-238. doi: 10.5115/acb.21.233 PMID: 35668476
  86. Saito, Y.; Imazeki, H.; Miura, S.; Yoshimura, T.; Okutsu, H.; Harada, Y.; Ohwaki, T.; Nagao, O.; Kamiya, S.; Hayashi, R.; Kodama, H.; Handa, H.; Yoshida, T.; Fukai, F. A peptide derived from tenascin-C induces β1 integrin activation through syndecan-4. J. Biol. Chem., 2007, 282(48), 34929-34937. doi: 10.1074/jbc.M705608200 PMID: 17901052
  87. Thodeti, C.K.; Albrechtsen, R.; Grauslund, M.; Asmar, M.; Larsson, C.; Takada, Y.; Mercurio, A.M.; Couchman, J.R.; Wewer, U.M. ADAM12/syndecan-4 signaling promotes β 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA. J. Biol. Chem., 2003, 278(11), 9576-9584. doi: 10.1074/jbc.M208937200 PMID: 12509413
  88. Midwood, K.S.; Schwarzbauer, J.E. Tenascin-C modulates matrix contraction via focal adhesion kinase- and Rho-mediated signaling pathways. Mol. Biol. Cell, 2002, 13(10), 3601-3613. doi: 10.1091/mbc.e02-05-0292 PMID: 12388760
  89. Trebaul, A.; Chan, E.K.; Midwood, K.S. Regulation of fibroblast migration by tenascin-C. Biochem. Soc. Trans., 2007, 35(4), 695-697. doi: 10.1042/BST0350695 PMID: 17635125
  90. Matsuda, A.; Yoshiki, A.; Tagawa, Y.; Matsuda, H.; Kusakabe, M. Corneal wound healing in tenascin knockout mouse. Invest. Ophthalmol. Vis. Sci., 1999, 40(6), 1071-1080. PMID: 10235540
  91. El-Karef, A; Yoshida, T; Gabazza, E; Nishioka, T; Inada, H; Sakakura, T Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice. J. Pathol., 2007, 211(1), 86-94. doi: 10.1002/path.2099
  92. Mane, D.R.; Rahman, S.U.; Desai, K.M.; Kale, A.D.; Bhat, K.G.; Arany, P.R. Roles of the matricellular protein Tenascin-C in T-lymphocyte trafficking and etiopathogenesis of Oral Lichen Planus. Arch. Oral Biol., 2020, 110, 104622. doi: 10.1016/j.archoralbio.2019.104622 PMID: 31783297
  93. Clark, R.A.; Erickson, H.P.; Springer, T.A. Tenascin supports lymphocyte rolling. J. Cell Biol., 1997, 137(3), 755-765. doi: 10.1083/jcb.137.3.755 PMID: 9151679
  94. Wang, Z.; Wei, Q.; Han, L.; Cao, K.; Lan, T.; Xu, Z.; Wang, Y.; Gao, Y.; Xue, J.; Shan, F.; Feng, J.; Xie, X. Tenascin-c renders a proangiogenic phenotype in macrophage via annexin II. J. Cell. Mol. Med., 2018, 22(1), 429-438. doi: 10.1111/jcmm.13332 PMID: 28857429
  95. Davies, M.G.; Hagen, P-O. Pathobiology of intimal hyperplasia. Br. J. Surg., 2005, 81(9), 1254-1269. doi: 10.1002/bjs.1800810904 PMID: 7953384
  96. Malabanan, K.P.; Sheahan, A.V.; Khachigian, L.M. Platelet-derived growth factor-BB mediates cell migration through induction of activating transcription factor 4 and tenascin-C. Am. J. Pathol., 2012, 180(6), 2590-2597. doi: 10.1016/j.ajpath.2012.02.009 PMID: 22507839
  97. Ljubimov, A.V.; Burgeson, R.E.; Butkowski, R.J.; Couchman, J.R.; Zardi, L.; Ninomiya, Y.; Sado, Y.; Huang, Z.S.; Nesburn, A.B.; Kenney, M.C. Basement membrane abnormalities in human eyes with diabetic retinopathy. J. Histochem. Cytochem., 1996, 44(12), 1469-1479. doi: 10.1177/44.12.8985139 PMID: 8985139
  98. Spirin, K.S.; Saghizadeh, M.; Lewin, S.L.; Zardi, L.; Kenney, M.C.; Ljubimov, A.V. Basement membrane and growth factor gene expression in normal and diabetic human retinas. Curr. Eye Res., 1999, 18(6), 490-499. doi: 10.1076/ceyr.18.6.490.5267 PMID: 10435836
  99. Castellon, R.; Caballero, S.; Hamdi, H.K.; Atilano, S.R.; Aoki, A.M.; Tarnuzzer, R.W.; Kenney, M.C.; Grant, M.B.; Ljubimov, A.V. Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture. Invest. Ophthalmol. Vis. Sci., 2002, 43(8), 2758-2766. PMID: 12147613
  100. Joester, A.; Faissner, A. The structure and function of tenascins in the nervous system. Matrix Biol., 2001, 20(1), 13-22. doi: 10.1016/S0945-053X(00)00136-0 PMID: 11246000
  101. Fujioka, T.; Kaneko, N.; Ajioka, I.; Nakaguchi, K.; Omata, T.; Ohba, H.; Fässler, R.; García-Verdugo, J.M.; Sekiguchi, K.; Matsukawa, N.; Sawamoto, K. β1 integrin signaling promotes neuronal migration along vascular scaffolds in the post-stroke brain. EBioMedicine, 2017, 16, 195-203. doi: 10.1016/j.ebiom.2017.01.005 PMID: 28153772
  102. Kiernan, B.W.; Götz, B.; Faissner, A.; ffrench-Constant, C. Tenascin-C inhibits oligodendrocyte precursor cell migration by both adhesion-dependent and adhesion-independent mechanisms. Mol. Cell. Neurosci., 1996, 7(4), 322-335. doi: 10.1006/mcne.1996.0024 PMID: 8793866
  103. Wiese, S.; Karus, M.; Faissner, A. Astrocytes as a source for extracellular matrix molecules and cytokines. Front. Pharmacol., 2012, 3, 120. doi: 10.3389/fphar.2012.00120 PMID: 22740833
  104. Carnemolla, B.; Castellani, P.; Ponassi, M.; Borsi, L.; Urbini, S.; Nicolo, G.; Dorcaratto, A.; Viale, G.; Winter, G.; Neri, D.; Zardi, L. Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody. Am. J. Pathol., 1999, 154(5), 1345-1352. doi: 10.1016/S0002-9440(10)65388-6 PMID: 10329587
  105. Joester, A.; Faissner, A. Evidence for combinatorial variability of tenascin-C isoforms and developmental regulation in the mouse central nervous system. J. Biol. Chem., 1999, 274(24), 17144-17151. doi: 10.1074/jbc.274.24.17144 PMID: 10358070
  106. Tucker, R.P. Abnormal neural crest cell migration after the in vivo knockdown of tenascin-C expression with morpholino antisense oligonucleotides. Dev. Dyn., 2001, 222(1), 115-119. doi: 10.1002/dvdy.1171 PMID: 11507773
  107. Halfter, W.; Chiquet-Ehrismann, R.; Tucker, R.P. The effect of tenascin and embryonic basal lamina on the behavior and morphology of neural crest cells in vitro . Dev. Biol., 1989, 132(1), 14-25. doi: 10.1016/0012-1606(89)90200-5 PMID: 2465193
  108. Radwanska, A.; Grall, D.; Schaub, S.; Divonne, S.B.F.; Ciais, D.; Rekima, S.; Rupp, T.; Sudaka, A.; Orend, G.; Van Obberghen-Schilling, E. Counterbalancing anti-adhesive effects of Tenascin-C through fibronectin expression in endothelial cells. Sci. Rep., 2017, 7(1), 12762. doi: 10.1038/s41598-017-13008-9 PMID: 28986537
  109. Yalcin, F.; Dzaye, O.; Xia, S. Tenascin-C Function in Glioma: Immunomodulation and Beyond. Tumor Microenvironment; Springer, 2020, pp. 149-172.
  110. Nakahara, H.; Gabazza, E.C.; Fujimoto, H.; Nishii, Y.; D’Alessandro-Gabazza, C.N.; Bruno, N.E.; Takagi, T.; Hayashi, T.; Maruyama, J.; Maruyama, K.; Imanaka-Yoshida, K.; Suzuki, K.; Yoshida, T.; Adachi, Y.; Taguchi, O. Deficiency of tenascin C attenuates allergen-induced bronchial asthma in the mouse. Eur. J. Immunol., 2006, 36(12), 3334-3345. doi: 10.1002/eji.200636271 PMID: 17125141
  111. Jayaraj, R.L.; Azimullah, S.; Beiram, R.; Jalal, F.Y.; Rosenberg, G.A. Neuroinflammation: Friend and foe for ischemic stroke. J. Neuroinflammation, 2019, 16(1), 142. doi: 10.1186/s12974-019-1516-2 PMID: 31291966
  112. Haage, V.; Elmadany, N.; Roll, L.; Faissner, A.; Gutmann, D.H.; Semtner, M.; Kettenmann, H. Tenascin C regulates multiple microglial functions involving TLR4 signaling and HDAC1. Brain Behav. Immun., 2019, 81, 470-483. doi: 10.1016/j.bbi.2019.06.047 PMID: 31271872
  113. Caso, J.R.; Pradillo, J.M.; Hurtado, O.; Lorenzo, P.; Moro, M.A.; Lizasoain, I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation, 2007, 115(12), 1599-1608. doi: 10.1161/CIRCULATIONAHA.106.603431 PMID: 17372179
  114. Neumann, J.; Riek-Burchardt, M.; Herz, J.; Doeppner, T.R.; König, R.; Hütten, H.; Etemire, E.; Männ, L.; Klingberg, A.; Fischer, T.; Görtler, M.W.; Heinze, H.J.; Reichardt, P.; Schraven, B.; Hermann, D.M.; Reymann, K.G.; Gunzer, M. Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke. Acta Neuropathol., 2015, 129(2), 259-277. doi: 10.1007/s00401-014-1355-2 PMID: 25391494
  115. Manrique-Castano, D.; Dzyubenko, E.; Borbor, M.; Vasileiadou, P.; Kleinschnitz, C.; Roll, L.; Faissner, A.; Hermann, D.M. Tenascin-C preserves microglia surveillance and restricts leukocyte and, more specifically, T cell infiltration of the ischemic brain. Brain Behav. Immun., 2021, 91, 639-648. doi: 10.1016/j.bbi.2020.10.016 PMID: 33122023
  116. Kon, S.; Uede, T. The role of α9β1 integrin and its ligands in the development of autoimmune diseases. J. Cell Commun. Signal., 2018, 12(1), 333-342. doi: 10.1007/s12079-017-0413-7 PMID: 28975544
  117. Song, J.; Schwenzer, A.; Wong, A.; Turcinov, S.; Rims, C.; Martinez, L.R.; Arribas-Layton, D.; Gerstner, C.; Muir, V.S.; Midwood, K.S.; Malmström, V.; James, E.A.; Buckner, J.H. Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis. JCI Insight, 2021, 6(5), e145217. doi: 10.1172/jci.insight.145217 PMID: 33507879
  118. Momčilović, M.; Stamenković, V.; Jovanović, M.; Andjus, P.R.; Jakovčevski, I.; Schachner, M.; Miljković, Đ. Tenascin-C deficiency protects mice from experimental autoimmune encephalomyelitis. J. Neuroimmunol., 2017, 302, 1-6. doi: 10.1016/j.jneuroim.2016.12.001 PMID: 27974153
  119. Machino-Ohtsuka, T.; Tajiri, K.; Kimura, T.; Sakai, S.; Sato, A.; Yoshida, T.; Hiroe, M.; Yasutomi, Y.; Aonuma, K.; Imanaka-Yoshida, K. Tenascin-C aggravates autoimmune myocarditis via dendritic cell activation and Th17 cell differentiation. J. Am. Heart Assoc., 2014, 3(6), e001052. doi: 10.1161/JAHA.114.001052 PMID: 25376187
  120. Bauch, J.; Faissner, A. The extracellular matrix proteins tenascin-c and tenascin-r retard oligodendrocyte precursor maturation and myelin regeneration in a cuprizone-induced long-term demyelination animal model. Cells, 2022, 11(11), 1773. doi: 10.3390/cells11111773 PMID: 35681468
  121. Franklin, R.J.M.; ffrench-Constant, C. Regenerating CNS myelin — from mechanisms to experimental medicines. Nat. Rev. Neurosci., 2017, 18(12), 753-769. doi: 10.1038/nrn.2017.136 PMID: 29142295
  122. Czopka, T.; Von Holst, A.; Schmidt, G.; Ffrench-Constant, C.; Faissner, A. Tenascin C and tenascin R similarly prevent the formation of myelin membranes in a RhoA-dependent manner, but antagonistically regulate the expression of myelin basic protein via a separate pathway. Glia, 2009, 57(16), 1790-1801. doi: 10.1002/glia.20891 PMID: 19459213
  123. Wenk, M.B.; Midwood, K.S.; Schwarzbauer, J.E. Tenascin-C suppresses Rho activation. J. Cell Biol., 2000, 150(4), 913-920. doi: 10.1083/jcb.150.4.913 PMID: 10953015
  124. Galon, J.; Costes, A.; Sanchez-Cabo, F.; Kirilovsky, A.; Mlecnik, B.; Lagorce-Pagès, C.; Tosolini, M.; Camus, M.; Berger, A.; Wind, P.; Zinzindohoué, F.; Bruneval, P.; Cugnenc, P.H.; Trajanoski, Z.; Fridman, W.H.; Pagès, F. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science, 2006, 313(5795), 1960-1964. doi: 10.1126/science.1129139 PMID: 17008531
  125. Huang, J.Y.; Cheng, Y.J.; Lin, Y.P.; Lin, H.C.; Su, C.C.; Juliano, R.; Yang, B.C. Extracellular matrix of glioblastoma inhibits polarization and transmigration of T cells: the role of tenascin-C in immune suppression. J. Immunol., 2010, 185(3), 1450-1459. doi: 10.4049/jimmunol.0901352 PMID: 20622113
  126. Jachetti, E.; Caputo, S.; Mazzoleni, S.; Brambillasca, C.S.; Parigi, S.M.; Grioni, M.; Piras, I.S.; Restuccia, U.; Calcinotto, A.; Freschi, M.; Bachi, A.; Galli, R.; Bellone, M. Tenascin-C protects cancer stem–like cells from immune surveillance by arresting T-cell activation. Cancer Res., 2015, 75(10), 2095-2108. doi: 10.1158/0008-5472.CAN-14-2346 PMID: 25808872
  127. Su, C.C.; Lin, Y.P.; Cheng, Y.J.; Huang, J.Y.; Chuang, W.J.; Shan, Y.S.; Yang, B.C. Phosphatidylinositol 3-kinase/Akt activation by integrin-tumor matrix interaction suppresses Fas-mediated apoptosis in T cells. J. Immunol., 2007, 179(7), 4589-4597. doi: 10.4049/jimmunol.179.7.4589 PMID: 17878356
  128. Loike, J.D.; Cao, L.; Budhu, S.; Hoffman, S.; Silverstein, S.C. Blockade of α 5 β 1 integrins reverses the inhibitory effect of tenascin on chemotaxis of human monocytes and polymorphonuclear leukocytes through three-dimensional gels of extracellular matrix proteins. J. Immunol., 2001, 166(12), 7534-7542. doi: 10.4049/jimmunol.166.12.7534 PMID: 11390508
  129. Hauzenberger, D.; Olivier, P.; Gundersen, D.; Rüegg, C. Tenascin-C inhibits β1 integrin-dependent T lymphocyte adhesion to fibronectin through the binding of its fnIII 1 – 5 repeats to fibronectin. Eur. J. Immunol., 1999, 29(5), 1435-1447. doi: 10.1002/(SICI)1521-4141(199905)29:053.0.CO;2-N PMID: 10359097
  130. Rougerie, P.; Delon, J. Rho GTPases: Masters of T lymphocyte migration and activation. Immunol. Lett., 2012, 142(1-2), 1-13. doi: 10.1016/j.imlet.2011.12.003 PMID: 22207038
  131. Tybulewicz, V.L.J.; Henderson, R.B. Rho family GTPases and their regulators in lymphocytes. Nat. Rev. Immunol., 2009, 9(9), 630-644. doi: 10.1038/nri2606 PMID: 19696767
  132. Mackie, E.J.; Tucker, R.P. The tenascin-C knockout revisited. J. Cell Sci., 1999, 112(22), 3847-3853. doi: 10.1242/jcs.112.22.3847 PMID: 10547346
  133. Mangan, R.J.; Stamper, L.; Ohashi, T.; Eudailey, J.A.; Go, E.P.; Jaeger, F.H.; Itell, H.L.; Watts, B.E.; Fouda, G.G.; Erickson, H.P.; Alam, S.M.; Desaire, H.; Permar, S.R. Determinants of Tenascin-C and HIV-1 envelope binding and neutralization. Mucosal Immunol., 2019, 12(4), 1004-1012. doi: 10.1038/s41385-019-0164-2 PMID: 30976088
  134. Sur, S.; Khatun, M.; Steele, R.; Isbell, T.S.; Ray, R.; Ray, R.B. Exosomes from COVID-19 patients carry Tenascin-C and Fibrinogen-β in triggering inflammatory signals in cells of distant organ. Int. J. Mol. Sci., 2021, 22(6), 3184. doi: 10.3390/ijms22063184 PMID: 33804769
  135. Amemiya, K.; Kobayashi, T.; Kataoka, Y.; Iwai, T.; Nakagawa, S.; Morita, Y.; Ohta-Ogo, K.; Matsumoto, M.; Ikeda, Y.; Katano, H.; Suzuki, T.; Izumi, C.; Noguchi, T.; Hatakeyama, K. Myocarditis after COVID-19 mRNA vaccination in three young adult males: Significance of biopsy in vaccine-associated myocarditis. Pathol. Int., 2022, 72(7), 385-387. doi: 10.1111/pin.13234 PMID: 35583173
  136. Tajiri, K.; Yonebayashi, S.; Li, S.; Ieda, M. Immunomodulatory role of tenascin-C in myocarditis and inflammatory cardiomyopathy. Front. Immunol., 2021, 12, 624703. doi: 10.3389/fimmu.2021.624703 PMID: 33692798
  137. Zeng, H.L.; Chen, D.; Yan, J.; Yang, Q.; Han, Q.Q.; Li, S.S.; Cheng, L. Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID-19 patients. FEBS J., 2021, 288(17), 5190-5200. doi: 10.1111/febs.15609 PMID: 33098359
  138. Zuliani-Alvarez, L.; Piccinini, A.M. A virological view of tenascin-C in infection. Am. J. Physiol. Cell Physiol., 2023, 324(1), C1-C9. doi: 10.1152/ajpcell.00333.2022 PMID: 36458980
  139. Yuan, W.; Zhang, W.; Yang, X.; Zhou, L.; Hanghua, Z.; Xu, K. Clinical significance and prognosis of serum tenascin-C in patients with sepsis. BMC Anesthesiol., 2018, 18(1), 170. doi: 10.1186/s12871-018-0634-1 PMID: 30442110
  140. Albacete-Albacete, L.; Navarro-Lérida, I.; López, J.A.; Martín-Padura, I.; Astudillo, A.M.; Ferrarini, A.; Van-Der-Heyden, M.; Balsinde, J.; Orend, G.; Vázquez, J.; del Pozo, M.Á. ECM deposition is driven by caveolin-1–dependent regulation of exosomal biogenesis and cargo sorting. J. Cell Biol., 2020, 219(11), e202006178. doi: 10.1083/jcb.202006178 PMID: 33053168
  141. Campos, A.; Salomon, C.; Bustos, R.; Díaz, J.; Martínez, S.; Silva, V.; Reyes, C.; Díaz-Valdivia, N.; Varas-Godoy, M.; Lobos-González, L.; Quest, A.F.G. Caveolin-1-containing extracellular vesicles transport adhesion proteins and promote malignancy in breast cancer cell lines. Nanomedicine, 2018, 13(20), 2597-2609. doi: 10.2217/nnm-2018-0094 PMID: 30338706
  142. Ji, H.; Greening, D.W.; Barnes, T.W.; Lim, J.W.; Tauro, B.J.; Rai, A.; Xu, R.; Adda, C.; Mathivanan, S.; Zhao, W.; Xue, Y.; Xu, T.; Zhu, H.J.; Simpson, R.J. Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. Proteomics, 2013, 13(10-11), 1672-1686. doi: 10.1002/pmic.201200562 PMID: 23585443
  143. Zheng, J.; Hernandez, J.M.; Doussot, A.; Bojmar, L.; Zambirinis, C.P.; Costa-Silva, B.; van Beek, E.J.A.H.; Mark, M.T.; Molina, H.; Askan, G.; Basturk, O.; Gonen, M.; Kingham, T.P.; Allen, P.J.; D’Angelica, M.I.; DeMatteo, R.P.; Lyden, D.; Jarnagin, W.R. Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer. HPB, 2018, 20(7), 597-604. doi: 10.1016/j.hpb.2017.12.010 PMID: 29339034
  144. Mirzaei, R.; Sarkar, S.; Dzikowski, L.; Rawji, K.S.; Khan, L.; Faissner, A. Brain tumor-initiating cells export tenascin-C associated with exosomes to suppress T cell activity; Taylor & Francis, 2018. doi: 10.1080/2162402X.2018.1478647
  145. Pedretti, M.; Soltermann, A.; Arni, S.; Weder, W.; Neri, D.; Hillinger, S. Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: Two human antibodies investigated in clinical trials in patients with cancer. Lung Cancer, 2009, 64(1), 28-33. doi: 10.1016/j.lungcan.2008.07.013 PMID: 18799229
  146. Niebroj-Dobosz, I; Madej-Pilarczyk, A; Marchel, M Circulating tenascin-C levels in patients with dilated cardiomyopathy in the course of Emery-Dreifuss muscular dystrophy. Clin Chim Acta, 2011, 412(17-18), 1533-1538. doi: 10.1016/j.cca.2011.04.033 PMID: 21596026
  147. Page, T.H.; Charles, P.J.; Piccinini, A.M.; Nicolaidou, V.; Taylor, P.C.; Midwood, K.S. Raised circulating tenascin-C in rheumatoid arthritis. Arthritis Res. Ther., 2012, 14(6), R260. doi: 10.1186/ar4105 PMID: 23193984
  148. Indumathi, A.; Senthilkumar, G.P.; Jayashree, K.; Ramesh Babu, K. Assessment of circulating fibrotic proteins (periostin and tenascin -C) In Type 2 diabetes mellitus patients with and without retinopathy. Endocrine, 2022, 76(3), 570-577. doi: 10.1007/s12020-022-03027-6 PMID: 35274283
  149. Tenascins in CNS lesions. Seminars in cell & developmental biology; Roll, L.; Faissner, A., Eds.; Elsevier, 2019.
  150. Hausmann, R.; Betz, P. Course of glial immunoreactivity for vimentin, tenascin and α1-antichymotrypsin after traumatic injury to human brain. Int. J. Legal Med., 2001, 114(6), 338-342. doi: 10.1007/s004140000199 PMID: 11508799
  151. Stamenkovic, V.; Stamenkovic, S.; Jaworski, T.; Gawlak, M.; Jovanovic, M.; Jakovcevski, I.; Wilczynski, G.M.; Kaczmarek, L.; Schachner, M.; Radenovic, L.; Andjus, P.R. The extracellular matrix glycoprotein tenascin-C and matrix metalloproteinases modify cerebellar structural plasticity by exposure to an enriched environment. Brain Struct. Funct., 2017, 222(1), 393-415. doi: 10.1007/s00429-016-1224-y PMID: 27089885
  152. Geissler, M.; Gottschling, C.; Aguado, A.; Rauch, U.; Wetzel, C.H.; Hatt, H.; Faissner, A. Primary hippocampal neurons, which lack four crucial extracellular matrix molecules, display abnormalities of synaptic structure and function and severe deficits in perineuronal net formation. J. Neurosci., 2013, 33(18), 7742-7755. doi: 10.1523/JNEUROSCI.3275-12.2013 PMID: 23637166
  153. Jansen, S.; Gottschling, C.; Faissner, A.; Manahan-Vaughan, D. Intrinsic cellular and molecular properties of in vivo hippocampal synaptic plasticity are altered in the absence of key synaptic matrix molecules. Hippocampus, 2017, 27(8), 920-933. doi: 10.1002/hipo.22742 PMID: 28512860
  154. Quattromani, M.J.; Hakon, J.; Rauch, U.; Bauer, A.Q.; Wieloch, T. Changes in resting-state functional connectivity after stroke in a mouse brain lacking extracellular matrix components. Neurobiol. Dis., 2018, 112, 91-105. doi: 10.1016/j.nbd.2018.01.011 PMID: 29367009
  155. Dzyubenko, E.; Manrique-Castano, D.; Kleinschnitz, C.; Faissner, A.; Hermann, D.M. Topological remodeling of cortical perineuronal nets in focal cerebral ischemia and mild hypoperfusion. Matrix Biol., 2018, 74, 121-132. doi: 10.1016/j.matbio.2018.08.001 PMID: 30092283
  156. Šekeljić, V.; Andjus, P.R. Tenascin-C and its functions in neuronal plasticity. Int. J. Biochem. Cell Biol., 2012, 44(6), 825-829. doi: 10.1016/j.biocel.2012.02.014 PMID: 22405938
  157. Wlodarczyk, J.; Mukhina, I.; Kaczmarek, L.; Dityatev, A. Extracellular matrix molecules, their receptors, and secreted proteases in synaptic plasticity. Dev. Neurobiol., 2011, 71(11), 1040-1053. doi: 10.1002/dneu.20958 PMID: 21793226
  158. Xie, K.; Liu, Y.; Hao, W.; Walter, S.; Penke, B.; Hartmann, T.; Schachner, M.; Fassbender, K. Tenascin-C deficiency ameliorates Alzheimer’s disease-related pathology in mice. Neurobiol. Aging, 2013, 34(10), 2389-2398. doi: 10.1016/j.neurobiolaging.2013.04.013 PMID: 23673309
  159. Scheffler, B.; Faissner, A.; Beck, H.; Behle, K.; Wolf, H.K.; Wiestler, O.D.; Blümcke, I. Hippocampal loss of tenascin boundaries in Ammon’s horn sclerosis. Glia, 1997, 19(1), 35-46. doi: 10.1002/(SICI)1098-1136(199701)19:13.0.CO;2-9 PMID: 8989566
  160. Mi, Z.; Halfter, W.; Abrahamson, E.E.; Klunk, W.E.; Mathis, C.A.; Mufson, E.J.; Ikonomovic, M.D. Tenascin-C is associated with cored amyloid-β plaques in Alzheimer disease and pathology burdened cognitively normal elderly. J. Neuropathol. Exp. Neurol., 2016, 75(9), 868-876. doi: 10.1093/jnen/nlw062 PMID: 27444354
  161. Hasanzadeh, Z.; Nourazarian, A.; Nikanfar, M.; Laghousi, D.; Vatankhah, A.M.; Sadrirad, S. Evaluation of the serum Dkk-1, tenascin-C, oxidative stress markers levels and Wnt signaling pathway genes expression in patients with Alzheimer’s disease. J. Mol. Neurosci., 2021, 71(4), 879-887. doi: 10.1007/s12031-020-01710-9 PMID: 32935274
  162. Soares, H.D.; Potter, W.Z.; Pickering, E.; Kuhn, M.; Immermann, F.W.; Shera, D.M.; Ferm, M.; Dean, R.A.; Simon, A.J.; Swenson, F.; Siuciak, J.A.; Kaplow, J.; Thambisetty, M.; Zagouras, P.; Koroshetz, W.J.; Wan, H.I.; Trojanowski, J.Q.; Shaw, L.M. Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease. Arch. Neurol., 2012, 69(10), 1310-1317. doi: 10.1001/archneurol.2012.1070 PMID: 22801723
  163. Morellini, F.; Schachner, M. Enhanced novelty-induced activity, reduced anxiety, delayed resynchronization to daylight reversal and weaker muscle strength in tenascin-C-deficient mice. Eur. J. Neurosci., 2006, 23(5), 1255-1268. doi: 10.1111/j.1460-9568.2006.04657.x PMID: 16553788
  164. Stamenkovic, V.; Milenkovic, I.; Galjak, N.; Todorovic, V.; Andjus, P. Enriched environment alters the behavioral profile of tenascin-C deficient mice. Behav. Brain Res., 2017, 331, 241-253. doi: 10.1016/j.bbr.2017.05.047 PMID: 28549651
  165. Hamza, O.; Kiss, A.; Kramer, A.M.; Trojanek, S.; Abraham, D.; Acar, E.; Nagel, F.; Tretter, V.E.; Kitzwögerer, M.; Podesser, B.K. Tenascin C promotes valvular remodeling in two large animal models of ischemic mitral regurgitation. Basic Res. Cardiol., 2020, 115(6), 76. doi: 10.1007/s00395-020-00837-5 PMID: 33258993
  166. Peng, R.; Li, Y. Associations between tenascin-C and testosterone deficiency in men with major depressive disorder: A cross-sectional retrospective study. J. Inflamm. Res., 2021, 14, 897-905. doi: 10.2147/JIR.S298270 PMID: 33758529
  167. Peng, R.; Dai, W.; Li, Y. High serum levels of tenascin-C are associated with suicide attempts in depressed patients. Psychiatry Res., 2018, 268, 60-64. doi: 10.1016/j.psychres.2018.06.069 PMID: 30005189
  168. Zhang, Z.; Yu, B.; Gu, Y.; Zhou, S.; Qian, T.; Wang, Y.; Ding, G.; Ding, F.; Gu, X. Fibroblast-derived tenascin-C promotes Schwann cell migration through β1-integrin dependent pathway during peripheral nerve regeneration. Glia, 2016, 64(3), 374-385. doi: 10.1002/glia.22934 PMID: 26497118
  169. Kwiatkowska, M.; Reinhard, J.; Roll, L.; Kraft, N.; Dazert, S.; Faissner, A.; Volkenstein, S. The expression pattern and inhibitory influence of Tenascin-C on the growth of spiral ganglion neurons suggest a regulatory role as boundary formation molecule in the postnatal mouse inner ear. Neuroscience, 2016, 319, 46-58. doi: 10.1016/j.neuroscience.2016.01.039 PMID: 26812032
  170. Dugu, L.; Hayashida, S.; Nakahara, T.; Xie, L.; Iwashita, Y.; Liu, X.; Uchi, H.; Tateuchi, S.; Takahara, M.; Oda, Y.; Moroi, Y.; Furue, M. Aberrant expression of tenascin-c and neuronatin in malignant peripheral nerve sheath tumors. Eur. J. Dermatol., 2010, 20(5), 580-584. PMID: 20610366
  171. Lu, P.; Takai, K.; Weaver, V.M.; Werb, Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb. Perspect. Biol., 2011, 3(12), a005058. doi: 10.1101/cshperspect.a005058 PMID: 21917992
  172. Dueck, M.; Riedl, S.; Hinz, U.; Tandara, A.; Möller, P.; Herfarth, C.; Faissner, A. Detection of tenascin-C isoforms in colorectal mucosa, ulcerative colitis, carcinomas and liver metastases. Int. J. Cancer, 1999, 82(4), 477-483. doi: 10.1002/(SICI)1097-0215(19990812)82:43.0.CO;2-5 PMID: 10404058
  173. Suzuki, H.; Sasada, M.; Kamiya, S.; Ito, Y.; Watanabe, H.; Okada, Y.; Ishibashi, K.; Iyoda, T.; Yanaka, A.; Fukai, F. The promoting effect of the extracellular matrix peptide TNIIIA2 derived from tenascin-C in colon cancer cell infiltration. Int. J. Mol. Sci., 2017, 18(1), 181. doi: 10.3390/ijms18010181 PMID: 28106752
  174. Silacci, M.; Brack, S.S.; Späth, N.; Buck, A.; Hillinger, S.; Arni, S.; Weder, W.; Zardi, L.; Neri, D. Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo. Protein Eng. Des. Sel., 2006, 19(10), 471-478. doi: 10.1093/protein/gzl033 PMID: 16928692
  175. Schwager, K.; Villa, A.; Rösli, C.; Neri, D.; Rösli-Khabas, M.; Moser, G. A comparative immunofluorescence analysis of three clinical-stage antibodies in head and neck cancer. Head Neck Oncol., 2011, 3(1), 25. doi: 10.1186/1758-3284-3-25 PMID: 21548989
  176. Frey, K.; Fiechter, M.; Schwager, K.; Belloni, B.; Barysch, M.J.; Neri, D.; Dummer, R. Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesions. Exp. Dermatol., 2011, 20(8), 685-688. doi: 10.1111/j.1600-0625.2011.01314.x PMID: 21649738
  177. Wilson, K.E.; Langdon, S.P.; Lessells, A.M.; Miller, W.R. Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours. Br. J. Cancer, 1996, 74(7), 999-1004. doi: 10.1038/bjc.1996.480 PMID: 8855965
  178. Adams, M.; Jones, J.L.; Walker, R.A.; Pringle, J.H.; Bell, S.C. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease. Cancer Res., 2002, 62(11), 3289-3297. PMID: 12036947
  179. Berndt, A.; Anger, K.; Richter, P.; Borsi, L.; Brack, S.; Silacci, M.; Franz, M.; Wunderlich, H.; Gajda, M.; Zardi, L.; Neri, D.; Kosmehl, H. Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder. J. Cancer Res. Clin. Oncol., 2006, 132(8), 537-546. doi: 10.1007/s00432-006-0106-8 PMID: 16788848
  180. Richter, P.; Tost, M.; Franz, M.; Altendorf-Hofmann, A.; Junker, K.; Borsi, L.; Neri, D.; Kosmehl, H.; Wunderlich, H.; Berndt, A. B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder? J. Cancer Res. Clin. Oncol., 2009, 135(10), 1351-1358. doi: 10.1007/s00432-009-0576-6 PMID: 19326143
  181. Guttery, D.S.; Hancox, R.A.; Mulligan, K.T.; Hughes, S.; Lambe, S.M.; Pringle, J.H.; Walker, R.A.; Jones, J.L.; Shaw, J.A. Association of invasion-promoting tenascin-C additional domains with breast cancers in young women. Breast Cancer Res., 2010, 12(4), R57. doi: 10.1186/bcr2618 PMID: 20678196
  182. Iyoda, T.; Fujita, M.; Fukai, F. Biologically active TNIIIA2 region in tenascin-C molecule: A major contributor to elicit aggressive malignant phenotypes from tumors/tumor stroma. Front. Immunol., 2020, 11, 610096. doi: 10.3389/fimmu.2020.610096 PMID: 33362799
  183. Hancox, R.A.; Allen, M.D.; Holliday, D.L.; Edwards, D.R.; Pennington, C.J.; Guttery, D.S.; Shaw, J.A.; Walker, R.A.; Pringle, J.H.; Jones, J.L. Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms. Breast Cancer Res., 2009, 11(2), R24. doi: 10.1186/bcr2251 PMID: 19405959
  184. Sun, Z.; Velázquez-Quesada, I.; Murdamoothoo, D.; Ahowesso, C.; Yilmaz, A.; Spenlé, C.; Averous, G.; Erne, W.; Oberndorfer, F.; Oszwald, A.; Kain, R.; Bourdon, C.; Mangin, P.; Deligne, C.; Midwood, K.; Abou-Faycal, C.; Lefebvre, O.; Klein, A.; van der Heyden, M.; Chenard, M.P.; Christofori, G.; Mathelin, C.; Loustau, T.; Hussenet, T.; Orend, G. Tenascin-C increases lung metastasis by impacting blood vessel invasions. Matrix Biol., 2019, 83, 26-47. doi: 10.1016/j.matbio.2019.07.001 PMID: 31288084
  185. Kasprzycka, M.; Hammarström, C.; Haraldsen, G. Tenascins in fibrotic disorders—from bench to bedside. Cell Adhes. Migr., 2015, 9(1-2), 83-89. doi: 10.4161/19336918.2014.994901 PMID: 25793575
  186. Katoh, D.; Kozuka, Y.; Noro, A.; Ogawa, T.; Imanaka-Yoshida, K.; Yoshida, T. Tenascin-C induces phenotypic changes in fibroblasts to myofibroblasts with high contractility through the integrin αvβ1/transforming growth factor β/SMAD signaling axis in human breast cancer. Am. J. Pathol., 2020, 190(10), 2123-2135. doi: 10.1016/j.ajpath.2020.06.008 PMID: 32650003
  187. Yeo, S.Y.; Lee, K.W.; Shin, D.; An, S.; Cho, K.H.; Kim, S.H. A positive feedback loop bi-stably activates fibroblasts. Nat. Commun., 2018, 9(1), 3016. doi: 10.1038/s41467-018-05274-6 PMID: 30069061
  188. Huang, W.; Chiquet-Ehrismann, R.; Moyano, J.V.; Garcia-Pardo, A.; Orend, G. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res., 2001, 61(23), 8586-8594. PMID: 11731446
  189. Fujita, M.; Sasada, M.; Iyoda, T.; Fukai, F. Involvement of integrin-activating peptides derived from tenascin-c in cancer aggression and new anticancer strategy using the fibronectin-derived integrin-inactivating peptide. Molecules, 2020, 25(14), 3239. doi: 10.3390/molecules25143239 PMID: 32708610
  190. Fujita, M.; Sasada, M.; Iyoda, T.; Osada, S.; Kodama, H.; Fukai, F. Biofunctional peptide FNIII14. Encyclopedia, 2021, 1(2), 350-359. doi: 10.3390/encyclopedia1020029
  191. Fujita, M.; Sasada, M.; Iyoda, T.; Nagai, R.; Kudo, C.; Yamamoto, T.; Osada, S.; Kodama, H.; Fukai, F. Anoikis resistance conferred by tenascin-C-derived peptide TNIIIA2 and its disruption by integrin inactivation. Biochem. Biophys. Res. Commun., 2021, 536, 14-19. doi: 10.1016/j.bbrc.2020.12.050 PMID: 33360093
  192. Swindle, C.S.; Tran, K.T.; Johnson, T.D.; Banerjee, P.; Mayes, A.M.; Griffith, L.; Wells, A. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J. Cell Biol., 2001, 154(2), 459-468. doi: 10.1083/jcb.200103103 PMID: 11470832
  193. Iyer, A.K.V.; Tran, K.T.; Borysenko, C.W.; Cascio, M.; Camacho, C.J.; Blair, H.C.; Bahar, I.; Wells, A. Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity. J. Cell. Physiol., 2007, 211(3), 748-758. doi: 10.1002/jcp.20986 PMID: 17311283
  194. Brösicke, N.; Faissner, A. Role of tenascins in the ECM of gliomas. Cell Adhes. Migr., 2015, 9(1-2), 131-140. doi: 10.1080/19336918.2014.1000071 PMID: 25695402
  195. Cai, J.; Lu, W.; Du, S.; Guo, Z.; Wang, H.; Wei, W.; Shen, X. Tenascin-C modulates cell cycle progression to enhance tumour cell proliferation through AKT/FOXO1 signalling in pancreatic cancer. J. Cancer, 2018, 9(23), 4449-4462. doi: 10.7150/jca.25926 PMID: 30519351
  196. Langlois, B.; Saupe, F.; Rupp, T.; Arnold, C.; van der Heyden, M.; Orend, G.; Hussenet, T. AngioMatrix, a signature of the tumor angiogenic switch-specific matrisome, correlates with poor prognosis for glioma and colorectal cancer patients. Oncotarget, 2014, 5(21), 10529-10545. doi: 10.18632/oncotarget.2470 PMID: 25301723
  197. Kubo, Y.; Ishikawa, K.; Mori, K.; Kobayashi, Y.; Nakama, T.; Arima, M.; Nakao, S.; Hisatomi, T.; Haruta, M.; Sonoda, K.H.; Yoshida, S. Periostin and tenascin-C interaction promotes angiogenesis in ischemic proliferative retinopathy. Sci. Rep., 2020, 10(1), 9299. doi: 10.1038/s41598-020-66278-1 PMID: 32518264
  198. Tanaka, K.; Hiraiwa, N.; Hashimoto, H.; Yamazaki, Y.; Kusakabe, M. Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression. Int. J. Cancer, 2004, 108(1), 31-40. doi: 10.1002/ijc.11509 PMID: 14618612
  199. Rupp, T.; Langlois, B.; Koczorowska, M.M.; Radwanska, A.; Sun, Z.; Hussenet, T.; Lefebvre, O.; Murdamoothoo, D.; Arnold, C.; Klein, A.; Biniossek, M.L.; Hyenne, V.; Naudin, E.; Velazquez-Quesada, I.; Schilling, O.; Van Obberghen-Schilling, E.; Orend, G. Tenascin-C orchestrates glioblastoma angiogenesis by modulation of pro-and anti-angiogenic signaling. Cell Rep., 2016, 17(10), 2607-2619. doi: 10.1016/j.celrep.2016.11.012 PMID: 27926865
  200. Fischer, D.; Brown-Lüdi, M.; Schulthess, T.; Chiquet-Ehrismann, R. Concerted action of tenascin-C domains in cell adhesion, anti-adhesion and promotion of neurite outgrowth. J. Cell Sci., 1997, 110(13), 1513-1522. doi: 10.1242/jcs.110.13.1513 PMID: 9224768
  201. Wawrzyniak, D.; Grabowska, M.; Głodowicz, P.; Kuczyński, K.; Kuczyńska, B.; Fedoruk-Wyszomirska, A.; Rolle, K. Down-regulation of tenascin-C inhibits breast cancer cells development by cell growth, migration, and adhesion impairment. PLoS One, 2020, 15(8), e0237889. doi: 10.1371/journal.pone.0237889 PMID: 32817625
  202. San Martin, R.; Pathak, R.; Jain, A.; Jung, S.Y.; Hilsenbeck, S.G.; Piña-Barba, M.C.; Sikora, A.G.; Pienta, K.J.; Rowley, D.R. Tenascin-C and integrin α9 mediate interactions of prostate cancer with the bone microenvironment. Cancer Res., 2017, 77(21), 5977-5988. doi: 10.1158/0008-5472.CAN-17-0064 PMID: 28916657
  203. Rappl, A.; Piontek, G.; Schlegel, J. EGFR-dependent migration of glial cells is mediated by reorganisation of N-cadherin. J. Cell Sci., 2008, 121(24), 4089-4097. doi: 10.1242/jcs.027995 PMID: 19033391
  204. Steitz, A.M.; Steffes, A.; Finkernagel, F.; Unger, A.; Sommerfeld, L.; Jansen, J.M.; Wagner, U.; Graumann, J.; Müller, R.; Reinartz, S. Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C. Cell Death Dis., 2020, 11(4), 249. doi: 10.1038/s41419-020-2438-8 PMID: 32312959
  205. Lange, K.; Kammerer, M.; Saupe, F.; Hegi, M.E.; Grotegut, S.; Fluri, E.; Orend, G. Combined lysophosphatidic acid/platelet-derived growth factor signaling triggers glioma cell migration in a tenascin-C microenvironment. Cancer Res., 2008, 68(17), 6942-6952. doi: 10.1158/0008-5472.CAN-08-0347 PMID: 18757408
  206. Sarkar, S.; Nuttall, R.K.; Liu, S.; Edwards, D.R.; Yong, V.W. Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. Cancer Res., 2006, 66(24), 11771-11780. doi: 10.1158/0008-5472.CAN-05-0470 PMID: 17178873
  207. Sarkar, S.; Zemp, F.J.; Senger, D.; Robbins, S.M.; Yong, V.W. ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor–initiating cells. Neuro-oncol., 2015, 17(8), 1095-1105. doi: 10.1093/neuonc/nou362 PMID: 25646025
  208. Hauzenberger, D.; Bergström, S.E.; Klominek, J.; Sundqvist, K.G. Spectrum of extracellular matrix degrading enzymes in normal and malignant T lymphocytes. Anticancer Res., 1999, 19(3A), 1945-1952. PMID: 10470139
  209. Benbow, J.H.; Thompson, K.J.; Cope, H.L.; Brandon-Warner, E.; Culberson, C.R.; Bossi, K.L.; Li, T.; Russo, M.W.; Gersin, K.S.; McKillop, I.H.; deLemos, A.S.; Schrum, L.W. Diet-induced obesity enhances progression of hepatocellular carcinoma through tenascin-C/toll-like receptor 4 signaling. Am. J. Pathol., 2016, 186(1), 145-158. doi: 10.1016/j.ajpath.2015.09.015 PMID: 26603137
  210. Hanmin, C.; Xiangyue, Z.; Lenahan, C.; Ling, W.; Yibo, O.; Yue, H. Pleiotropic role of tenascin-C in central nervous system diseases: From basic to clinical applications. Front. Neurol., 2020, 11, 576230. doi: 10.3389/fneur.2020.576230 PMID: 33281711
  211. Murdamoothoo, D.; Sun, Z.; Yilmaz, A.; Riegel, G.; Abou-Faycal, C.; Deligne, C.; Velazquez-Quesada, I.; Erne, W.; Nascimento, M.; Mörgelin, M.; Cremel, G.; Paul, N.; Carapito, R.; Veber, R.; Dumortier, H.; Yuan, J.; Midwood, K.S.; Loustau, T.; Orend, G. Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression. EMBO Mol. Med., 2021, 13(6), e13270. doi: 10.15252/emmm.202013270 PMID: 33988305
  212. Deligne, C.; Murdamoothoo, D.; Gammage, A.N.; Gschwandtner, M.; Erne, W.; Loustau, T.; Marzeda, A.M.; Carapito, R.; Paul, N.; Velazquez-Quesada, I.; Mazzier, I.; Sun, Z.; Orend, G.; Midwood, K.S. Matrix-targeting immunotherapy controls tumor growth and spread by switching macrophage phenotype. Cancer Immunol. Res., 2020, 8(3), 368-382. doi: 10.1158/2326-6066.CIR-19-0276 PMID: 31941671
  213. Spenlé, C.; Loustau, T.; Murdamoothoo, D.; Erne, W.; Beghelli-de la Forest Divonne, S.; Veber, R.; Petti, L.; Bourdely, P.; Mörgelin, M.; Brauchle, E.M.; Cremel, G.; Randrianarisoa, V.; Camara, A.; Rekima, S.; Schaub, S.; Nouhen, K.; Imhof, T.; Hansen, U.; Paul, N.; Carapito, R.; Pythoud, N.; Hirschler, A.; Carapito, C.; Dumortier, H.; Mueller, C.G.; Koch, M.; Schenke-Layland, K.; Kon, S.; Sudaka, A.; Anjuère, F.; Van Obberghen-Schilling, E.; Orend, G. Tenascin-C orchestrates an immune suppressive tumor microenvironment in oral squamous cell carcinoma. Cancer Immunol. Res., 2020, 8(9), 1122-1138. doi: 10.1158/2326-6066.CIR-20-0074 PMID: 32665262
  214. Wang, Y.; Xu, H.; Zhu, B.; Qiu, Z.; Lin, Z. Systematic identification of the key candidate genes in breast cancer stroma. Cell. Mol. Biol. Lett., 2018, 23(1), 44. doi: 10.1186/s11658-018-0110-4 PMID: 30237810
  215. Hongu, T.; Pein, M.; Insua-Rodríguez, J.; Gutjahr, E.; Mattavelli, G.; Meier, J.; Decker, K.; Descot, A.; Bozza, M.; Harbottle, R.; Trumpp, A.; Sinn, H.P.; Riedel, A.; Oskarsson, T. Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs. Nat. Can., 2022, 3(4), 486-504. doi: 10.1038/s43018-022-00353-6 PMID: 35469015
  216. Islam, M.S.; Kusakabe, M.; Horiguchi, K.; Iino, S.; Nakamura, T.; Iwanaga, K.; Hashimoto, H.; Matsumoto, S.; Murata, T.; Hori, M.; Ozaki, H. PDGF and TGF-β promote tenascin-C expression in subepithelial myofibroblasts and contribute to intestinal mucosal protection in mice. Br. J. Pharmacol., 2014, 171(2), 375-388. doi: 10.1111/bph.12452 PMID: 24116743
  217. Lu, Y.; Su, F.; Li, Q.; Zhang, J.; Li, Y.; Tang, T.; Hu, Q.; Yu, X.Q. Pattern recognition receptors in Drosophila immune responses. Dev. Comp. Immunol., 2020, 102, 103468. doi: 10.1016/j.dci.2019.103468 PMID: 31430488
  218. Kanayama, M.; Kurotaki, D.; Morimoto, J.; Asano, T.; Matsui, Y.; Nakayama, Y.; Saito, Y.; Ito, K.; Kimura, C.; Iwasaki, N.; Suzuki, K.; Harada, T.; Li, H.M.; Uehara, J.; Miyazaki, T.; Minami, A.; Kon, S.; Uede, T. α9 integrin and its ligands constitute critical joint microenvironments for development of autoimmune arthritis. J. Immunol., 2009, 182(12), 8015-8025. doi: 10.4049/jimmunol.0900725 PMID: 19494327
  219. Goh, F.G.; Piccinini, A.M.; Krausgruber, T.; Udalova, I.A.; Midwood, K.S. Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation. J. Immunol., 2010, 184(5), 2655-2662. doi: 10.4049/jimmunol.0903359 PMID: 20107185
  220. Imanaka-Yoshida, K. Tenascin-C in cardiovascular tissue remodeling: from development to inflammation and repair. Circ. J., 2012, 76(11), 2513-2520. doi: 10.1253/circj.CJ-12-1033 PMID: 23064399
  221. Fu, H.; Tian, Y.; Zhou, L.; Zhou, D.; Tan, R.J.; Stolz, D.B.; Liu, Y. Tenascin-C is a major component of the fibrogenic niche in kidney fibrosis. J. Am. Soc. Nephrol., 2017, 28(3), 785-801. doi: 10.1681/ASN.2016020165 PMID: 27612995
  222. Siddiqui, S.; Horvat-Bröcker, A.; Faissner, A. The glia-derived extracellular matrix glycoprotein tenascin-C promotes embryonic and postnatal retina axon outgrowth via the alternatively spliced fibronectin type III domain TNfnD. Neuron Glia Biol., 2008, 4(4), 271-283. doi: 10.1017/S1740925X09990020 PMID: 19508743
  223. Andrews, M.R.; Czvitkovich, S.; Dassie, E.; Vogelaar, C.F.; Faissner, A.; Blits, B.; Gage, F.H.; ffrench-Constant, C.; Fawcett, J.W. α9 integrin promotes neurite outgrowth on tenascin-C and enhances sensory axon regeneration. J. Neurosci., 2009, 29(17), 5546-5557. doi: 10.1523/JNEUROSCI.0759-09.2009 PMID: 19403822
  224. Imanaka-Yoshida, K.; Hiroe, M.; Nishikawa, T.; Ishiyama, S.; Shimojo, T.; Ohta, Y.; Sakakura, T.; Yoshida, T. Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction. Lab. Invest., 2001, 81(7), 1015-1024. doi: 10.1038/labinvest.3780313 PMID: 11454990
  225. Collins, A.R.; Schnee, J.; Wang, W.; Kim, S.; Fishbein, M.C.; Bruemmer, D.; Law, R.E.; Nicholas, S.; Ross, R.S.; Hsueh, W.A. Osteopontin modulates angiotensin II- induced fibrosis in the intact murine heart. J. Am. Coll. Cardiol., 2004, 43(9), 1698-1705. doi: 10.1016/j.jacc.2003.11.058 PMID: 15120833
  226. Settles, D.L.; Cihak, R.A.; Erickson, H.P. Tenascin-C expression in dystrophin-related muscular dystrophy. Muscle Nerve, 1996, 19(2), 147-154. doi: 10.1002/(SICI)1097-4598(199602)19:23.0.CO;2-E PMID: 8559162
  227. Kääriäinen, M.; Järvinen, T.; Järvinen, M.; Rantanen, J.; Kalimo, H. Relation between myofibers and connective tissue during muscle injury repair. Scand. J. Med. Sci. Sports, 2000, 10(6), 332-337. doi: 10.1034/j.1600-0838.2000.010006332.x PMID: 11085560
  228. Hamada, K.; Miura, Y.; Toma, N.; Miyamoto, K.; Imanaka-Yoshida, K.; Matsushima, S.; Yoshida, T.; Taki, W.; Suzuki, H. Gellan sulfate core platinum coil with tenascin-C promotes intra-aneurysmal organization in rats. Transl. Stroke Res., 2014, 5(5), 595-603. doi: 10.1007/s12975-014-0352-z PMID: 24939607
  229. Clark, R.A.F. Biology of dermal wound repair. Dermatol. Clin., 1993, 11(4), 647-666. doi: 10.1016/S0733-8635(18)30218-3 PMID: 8222349
  230. Patel, S. Danger-associated molecular patterns (DAMPs): the derivatives and triggers of inflammation. Curr. Allergy Asthma Rep., 2018, 18(11), 63. doi: 10.1007/s11882-018-0817-3 PMID: 30267163
  231. Liabeuf, S.; Barreto, D.V.; Kretschmer, A.; Barreto, F.C.; Renard, C.; Andrejak, M.; Choukroun, G.; Massy, Z. High circulating levels of large splice variants of tenascin-C is associated with mortality and cardiovascular disease in chronic kidney disease patients. Atherosclerosis, 2011, 215(1), 116-124. doi: 10.1016/j.atherosclerosis.2010.11.038 PMID: 21183183
  232. Zhu, H.; Liao, J.; Zhou, X.; Hong, X.; Song, D.; Hou, F.F.; Liu, Y.; Fu, H. Tenascin-C promotes acute kidney injury to chronic kidney disease progression by impairing tubular integrity via αvβ6 integrin signaling. Kidney Int., 2020, 97(5), 1017-1031. doi: 10.1016/j.kint.2020.01.026 PMID: 32245660
  233. Yasuda, M.; Harada, N.; Harada, S.; Ishimori, A.; Katsura, Y.; Itoigawa, Y.; Matsuno, K.; Makino, F.; Ito, J.; Ono, J.; Tobino, K.; Akiba, H.; Atsuta, R.; Izuhara, K.; Takahashi, K. Characterization of tenascin-C as a novel biomarker for asthma: Utility of tenascin-C in combination with periostin or immunoglobulin E. Allergy Asthma Clin. Immunol., 2018, 14(1), 72. doi: 10.1186/s13223-018-0300-7 PMID: 30473714
  234. Johannson, K.A.; Kolb, M.; Fell, C.D.; Assayag, D.; Fisher, J.; Churg, A. Evaluation of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society position statement; Taylor & Francis, 2017.
  235. Taş, İ.; Zhou, R.; Park, S.Y.; Yang, Y.; Gamage, C.D.B.; Son, Y.J.; Paik, M.J.; Kim, H. Inflammatory and tumorigenic effects of environmental pollutants found in particulate matter on lung epithelial cells. Toxicol. In Vitro, 2019, 59, 300-311. doi: 10.1016/j.tiv.2019.05.022 PMID: 31154059
  236. Carey, W.A.; Taylor, G.D.; Dean, W.B.; Bristow, J.D. Tenascin-C deficiency attenuates TGF-β-mediated fibrosis following murine lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol., 2010, 299(6), L785-L793. doi: 10.1152/ajplung.00385.2009 PMID: 20833777
  237. Clancy, P.; Lincz, L.F.; Maguire, J.; McEvoy, M.; Koblar, S.A.; Golledge, J. Tenascin-C is increased in atherothrombotic stroke patients and has an anti-inflammatory effect in the human carotid artery. Biofactors, 2014, 40(4), 448-457. doi: 10.1002/biof.1170 PMID: 24823872
  238. Liu, L.; Fujimoto, M.; Nakano, F.; Nishikawa, H.; Okada, T.; Kawakita, F.; Imanaka-Yoshida, K.; Yoshida, T.; Suzuki, H. Deficiency of tenascin-C alleviates neuronal apoptosis and neuroinflammation after experimental subarachnoid hemorrhage in mice. Mol. Neurobiol., 2018, 55(11), 8346-8354. doi: 10.1007/s12035-018-1006-z PMID: 29546590
  239. Suzuki, H.; Kanamaru, K.; Suzuki, Y.; Aimi, Y.; Matsubara, N.; Araki, T.; Takayasu, M.; Kinoshita, N.; Imanaka-Yoshida, K.; Yoshida, T.; Taki, W. Tenascin-C is induced in cerebral vasospasm after subarachnoid hemorrhage in rats and humans: A pilot study. Neurol. Res., 2010, 32(2), 179-184. doi: 10.1179/174313208X355495 PMID: 19589197
  240. Shiba, M.; Suzuki, H.; Fujimoto, M.; Shimojo, N.; Imanaka-Yoshida, K.; Yoshida, T.; Kanamaru, K.; Matsushima, S.; Taki, W. Imatinib mesylate prevents cerebral vasospasm after subarachnoid hemorrhage via inhibiting tenascin-C expression in rats. Neurobiol. Dis., 2012, 46(1), 172-179. doi: 10.1016/j.nbd.2012.01.005 PMID: 22300707
  241. Chiquet, M.; Sarasa-Renedo, A.; Tunç-Civelek, V. Induction of tenascin-C by cyclic tensile strain versus growth factors: distinct contributions by Rho/ROCK and MAPK signaling pathways. Biochim. Biophys. Acta Mol. Cell Res., 2004, 1693(3), 193-204. doi: 10.1016/j.bbamcr.2004.08.001 PMID: 15363633
  242. Fujimoto, M.; Shiba, M.; Kawakita, F.; Liu, L.; Shimojo, N.; Imanaka-Yoshida, K.; Yoshida, T.; Suzuki, H. Deficiency of tenascin-C and attenuation of blood-brain barrier disruption following experimental subarachnoid hemorrhage in mice. J. Neurosurg., 2016, 124(6), 1693-1702. doi: 10.3171/2015.4.JNS15484 PMID: 26473781
  243. Cho, A.; Graves, J.; Reidy, M.A. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol., 2000, 20(12), 2527-2532. doi: 10.1161/01.ATV.20.12.2527 PMID: 11116048
  244. Okada, T.; Suzuki, H. Mechanisms of neuroinflammation and inflammatory mediators involved in brain injury following subarachnoid hemorrhage. Histol. Histopathol., 2020, 35(7), 623-636. PMID: 32026458
  245. Hendryk, S.; Jarzab, B.; Josko, J. Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuroendocrinol. Lett., 2004, 25(1-2), 141-147. PMID: 15159698
  246. Suzuki, K.; Meguro, K.; Sakurai, T.; Saitoh, Y.; Takeuchi, S.; Nose, T. Endothelin-1 concentration increases in the cerebrospinal fluid in cerebral vasospasm caused by subarachnoid hemorrhage. Surg. Neurol., 2000, 53(2), 131-135. doi: 10.1016/S0090-3019(99)00179-2 PMID: 10713190
  247. Okada, T.; Kawakita, F.; Nishikawa, H.; Nakano, F.; Liu, L.; Suzuki, H. Selective toll-like receptor 4 antagonists prevent acute blood-brain barrier disruption after subarachnoid hemorrhage in mice. Mol. Neurobiol., 2019, 56(2), 976-985. doi: 10.1007/s12035-018-1145-2 PMID: 29855971
  248. Suzuki, H.; Fujimoto, M.; Kawakita, F.; Liu, L.; Nakatsuka, Y.; Nakano, F.; Nishikawa, H.; Okada, T.; Kanamaru, H.; Imanaka-Yoshida, K.; Yoshida, T.; Shiba, M. Tenascin-C in brain injuries and edema after subarachnoid hemorrhage: Findings from basic and clinical studies. J. Neurosci. Res., 2020, 98(1), 42-56. doi: 10.1002/jnr.24330 PMID: 30242870
  249. Suzuki, H.; Okada, T. Toll-like receptor 4 as a possible therapeutic target for delayed brain injuries after aneurysmal subarachnoid hemorrhage. Neural Regen. Res., 2017, 12(2), 193-196. doi: 10.4103/1673-5374.200795 PMID: 28400792
  250. Fujimoto, M.; Shiba, M.; Kawakita, F.; Liu, L.; Shimojo, N.; Imanaka-Yoshida, K.; Yoshida, T.; Suzuki, H. Effects of tenascin-C knockout on cerebral vasospasm after experimental subarachnoid hemorrhage in mice. Mol. Neurobiol., 2018, 55(3), 1951-1958. doi: 10.1007/s12035-017-0466-x PMID: 28244007

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Bentham Science Publishers